Module Database Search
MODULE DESCRIPTOR | |||
---|---|---|---|
Module Title | |||
General Pharmaceutical Care Provision | |||
Reference | PHM131 | Version | 6 |
Created | August 2021 | SCQF Level | SCQF 11 |
Approved | October 2013 | SCQF Points | 30 |
Amended | August 2021 | ECTS Points | 15 |
Aims of Module | |||
---|---|---|---|
To consolidate professional competence in pharmaceutical care through the integration of science with the application of a systematic approach to the management of individual patients with general pharmaceutical care needs. |
Learning Outcomes for Module | |
---|---|
On completion of this module, students are expected to be able to: | |
1 | Integrate understanding of pathophysiology, pharmacology, therapeutics, drug delivery and numerical data into pharmaceutical care plans. |
2 | Synthesise, document, justify and implement evidence based pharmaceutical care plans for individual patients with multiple problems. |
3 | Retrieve and critically evaluate information to solve therapeutic problems and inform the rational selection of medicines for individual patients. |
4 | Demonstrate attainment of relevant professional interpersonal communication skills. |
5 | Discuss and defend recommendations from evidence based pharmaceutical care plans. |
Indicative Module Content |
---|
Culmination of the integration of the themes, The Patient, The Medicine and The Pharmacist in the application of a systematic approach to pharmaceutical care. Topics include: current issues concerning the medical management of disease states of major body systems; aspects of clinical pharmacology and therapeutics including application of knowledge and understanding of physiology, pathology, pharmacology and therapeutics to patient care including interpretation of a variety of types of numerical data, including biochemical, haematological, and pharmacokinetic parameters; systematic approach to pharmaceutical care practice; structure and use of case notes; drug history taking; medical problem lists and pharmaceutical care issues and plans; recommendations for drug therapy, counselling, monitoring for efficacy and toxicity and evaluating patients' response; application of systems of medicines review such as the Chronic Medication Service. |
Module Delivery |
---|
Lectures, coursework sessions (to include individual and group problem solving exercises, tutorial sessions, placements and use of web based sources of information) and directed study activities. |
Indicative Student Workload | Full Time | Part Time |
---|---|---|
Contact Hours | 91 | N/A |
Non-Contact Hours | 209 | N/A |
Placement/Work-Based Learning Experience [Notional] Hours | N/A | N/A |
TOTAL | 300 | N/A |
Actual Placement hours for professional, statutory or regulatory body |   |   |
ASSESSMENT PLAN | |||||
---|---|---|---|---|---|
If a major/minor model is used and box is ticked, % weightings below are indicative only. | |||||
Component 1 | |||||
Type: | Practical Exam | Weighting: | 100% | Outcomes Assessed: | 1, 2, 3, 4, 5 |
Description: | An objective structured clinical examination. |
MODULE PERFORMANCE DESCRIPTOR | |
---|---|
Explanatory Text | |
Component 1 (PE1) comprises 100% of the module grade. A minimum of Grade D or better is required to pass the module. | |
Module Grade | Minimum Requirements to achieve Module Grade: |
A | A: a score of 70% or above is required and patient safety and legislation has been upheld. |
B | B: a score of between 60-69% is required and patient safety and legislation has been upheld. |
C | C: a score of between 50-59% is required and patient safety and legislation has been upheld. |
D | D: a score of between 40-49% is required and patient safety and legislation has been upheld. |
E | E: a score of between 35-39% is required and patient safety and legislation has been upheld. |
F | F: a score of less than 35% and/or patient safety and legislation has not been upheld. |
NS | Non-submission of work by published deadline or non-attendance for examination |
Module Requirements | |
---|---|
Prerequisites for Module | Successful completion of MPharm stage 3. |
Corequisites for module | None. |
Precluded Modules | None. |
INDICATIVE BIBLIOGRAPHY | |
---|---|
1 | BRITISH MEDICAL ASSOCIATION and ROYAL PHARMACEUTICAL SOCIETY. British National Formulary. Current edition. London: BMJ Group and Pharmaceutical Press. |
2 | BRITISH MEDICAL ASSOCIATION. Clinical Evidence. Current edition. London: BMJ Publications. |
3 | COLLEDGE, N.R., WALKER, B.R, RALSTON, S.H. (eds). Davidson's Principles and Practice of Medicine. Current edition. Edinburgh: Churchill Livingstone. |
4 | Other online evidence based therapeutic resources as stipulated during module delivery. |